Bull, base and bear scenarios, opening on what this business has actually done — its realised growth rates and its own P/E range, not round numbers we chose.
Projections are part of Pro
Set the growth, margin and multiple yourself and watch the price land where your assumptions put it — for Merck & Co., Inc. and every other company we cover.
Try it first on NVDA, AAPL, META or NKE, where it is open to everyone.
MRK · NYSE · ·
Next earnings: October 29, 2026 · before the open
$149.29+0.4%Sep 29 close
Merck makes prescription medicines and vaccines for people, and medicines, vaccines and monitoring products for animals.